TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9952762
log Bayes Factor = 0.0275078
Chromosome 18   position 73,401,650  (GRCh37) Explore rs9952762 on Ensembl!
Variant rs9952762 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K80.2 Calculus of gallbladder without cholecystitis
0.000 0.973 0.027
I44.2 Atrioventricular block, complete
0.000 0.973 0.027
K83 Other diseases of biliary tract
0.000 0.978 0.022
K83.1 Obstruction of bile duct
0.000 0.979 0.021
K80 Cholelithiasis
0.000 0.979 0.021
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.000 0.980 0.020
K83.0 Cholangitis
0.000 0.981 0.019
Y40.9 Systemic antibiotic, unspecified
0.019 0.981 0.000
K80.8 Other cholelithiasis
0.000 0.981 0.018
D64.9 Anaemia, unspecified
0.018 0.982 0.000
K81 Cholecystitis
0.000 0.982 0.018
K83.8 Other specified diseases of biliary tract
0.000 0.983 0.017
K85 Acute pancreatitis
0.000 0.983 0.017
K86 Other diseases of pancreas
0.000 0.983 0.017
Y40 Systemic antibiotics
0.017 0.983 0.000
K83.9 Disease of biliary tract, unspecified
0.000 0.984 0.016
K83.5 Biliary cyst
0.000 0.984 0.016
K83.4 Spasm of sphincter of Oddi
0.000 0.984 0.016
K83.3 Fistula of bile duct
0.000 0.984 0.016
K83.2 Perforation of bile duct
0.000 0.984 0.016
Y40.3 Macrolides
0.015 0.985 0.000
D64 Other anaemias
0.015 0.985 0.000
K80.4 Calculus of bile duct with cholecystitis
0.000 0.985 0.015
K80.3 Calculus of bile duct with cholangitis
0.000 0.985 0.015
K81.0 Acute cholecystitis
0.000 0.985 0.015
K86.3 Pseudocyst of pancreas
0.000 0.985 0.015
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
0.000 0.985 0.015
K85.1 Biliary acute pancreatitis
0.000 0.986 0.014
K86.0 Alcohol-induced chronic pancreatitis
0.000 0.986 0.014
K81.9 Cholecystitis, unspecified
0.000 0.986 0.014
Y40.1 Cefalosporins and other -lactam antibiotics
0.014 0.986 0.000
N20.1 Calculus of ureter
0.000 0.986 0.014
H54.0 Blindness, both eyes
0.013 0.987 0.000
Y40.0 Penicillins
0.013 0.987 0.000
D60-D64 Aplastic and other anaemias
0.013 0.987 0.000
K86.1 Other chronic pancreatitis
0.000 0.987 0.013
K81.8 Other cholecystitis
0.000 0.987 0.013
K85.9 Acute pancreatitis, unspecified
0.000 0.987 0.013
K80.0 Calculus of gallbladder with acute cholecystitis
0.000 0.987 0.013
D62 Acute posthaemorrhagic anaemia
0.012 0.987 0.000
K85.8 Other acute pancreatitis
0.000 0.988 0.012
K85.3 Drug-induced acute pancreatitis
0.000 0.988 0.012
K85.2 Alcohol-induced acute pancreatitis
0.000 0.988 0.012
K85.0 Idiopathic acute pancreatitis
0.000 0.988 0.012
Y40.7 Antifungal antibiotics, systemically used
0.012 0.988 0.000
Y40.6 Rifamycins
0.012 0.988 0.000
Y40.5 Aminoglycosides
0.012 0.988 0.000
Y40.4 Tetracyclines
0.012 0.988 0.000
Y40.2 Chloramphenicol group
0.012 0.988 0.000
K81.1 Chronic cholecystitis
0.000 0.988 0.012
K86.9 Disease of pancreas, unspecified
0.000 0.988 0.012
Y43 Primarily systemic agents
0.012 0.988 0.000
D61 Other aplastic anaemias
0.012 0.988 0.000
H54 Blindness and low vision
0.012 0.988 0.000
Y43.3 Other antineoplastic drugs
0.012 0.988 0.000
K86.8 Other specified diseases of pancreas
0.000 0.989 0.011
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.011 0.989 0.000
D64.8 Other specified anaemias
0.011 0.989 0.000
D64.4 Congenital dyserythropoietic anaemia
0.011 0.989 0.000
D64.3 Other sideroblastic anaemias
0.011 0.989 0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
0.011 0.989 0.000
D64.1 Secondary sideroblastic anaemia due to disease
0.011 0.989 0.000
D64.0 Hereditary sideroblastic anaemia
0.011 0.989 0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction
0.000 0.989 0.011
Y43.4 Immunosuppressive agents
0.011 0.989 0.000
D61.9 Aplastic anaemia, unspecified
0.011 0.989 0.000
K87.1 Disorders of pancreas in diseases classified elsewhere
0.000 0.989 0.011
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere
0.000 0.989 0.011
Y40.8 Other systemic antibiotics
0.011 0.989 0.000
N20 Calculus of kidney and ureter
0.000 0.990 0.010
H53 Visual disturbances
0.010 0.990 0.000
I51.9 Heart disease, unspecified
0.010 0.990 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.010 0.990 0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.010 0.990 0.000
H54.4 Blindness, one eye
0.010 0.990 0.000
K86.2 Cyst of pancreas
0.000 0.990 0.009
H53-H54 Visual disturbances and blindness
0.010 0.990 0.000
H53.0 Amblyopia ex anopsia
0.009 0.991 0.000
Y52 Agents primarily affecting the cardiovascular system
0.009 0.991 0.000
I44 Atrioventricular and left bundle-branch block
0.000 0.991 0.009
Y43.0 Antiallergic and antiemetic drugs
0.009 0.991 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.009 0.991 0.000
H53.4 Visual field defects
0.009 0.991 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
Y43.9 Primarily systemic agent, unspecified
0.009 0.991 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.009 0.991 0.000
Y43.6 Enzymes, not elsewhere classified
0.009 0.991 0.000
Y43.5 Acidifying and alkalising agents
0.009 0.991 0.000
Y43.2 Antineoplastic natural products
0.009 0.991 0.000
D61.8 Other specified aplastic anaemias
0.009 0.991 0.000
D61.3 Idiopathic aplastic anaemia
0.009 0.991 0.000
D61.2 Aplastic anaemia due to other external agents
0.009 0.991 0.000
D61.1 Drug-induced aplastic anaemia
0.009 0.991 0.000
D61.0 Constitutional aplastic anaemia
0.009 0.991 0.000
H54.7 Unspecified visual loss
0.009 0.991 0.000
H54.6 Unqualified visual loss, one eye
0.008 0.991 0.000
H54.5 Low vision, one eye
0.008 0.991 0.000
H54.3 Unqualified visual loss, both eyes
0.008 0.991 0.000
H54.2 Low vision, both eyes
0.008 0.991 0.000
H54.1 Blindness, one eye, low vision, other eye
0.008 0.991 0.000
H53.2 Diplopia
0.008 0.991 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.008 0.992 0.000
N23 Unspecified renal colic
0.000 0.992 0.008
Y49 Psychotropic drugs, not elsewhere classified
0.008 0.992 0.000
N20-N23 Urolithiasis
0.000 0.992 0.008
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.008 0.992 0.000
Y59 Other and unspecified vaccines and biological substances
0.008 0.992 0.000
Y58 Bacterial vaccines
0.008 0.992 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.008 0.992 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.008 0.992 0.000
Y48 Anaesthetics and therapeutic gases
0.008 0.992 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.008 0.992 0.000
Q60-Q64 Congenital malformations of the urinary system
0.008 0.992 0.000
Y46.6 Other and unspecified antiepileptics
0.008 0.992 0.000
Y57 Other and unspecified drugs and medicaments
0.008 0.992 0.000
H53.1 Subjective visual disturbances
0.008 0.992 0.000
H54.9 Unspecified visual impairment (binocular)
0.008 0.992 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.008 0.992 0.000
Q61 Cystic kidney disease
0.008 0.992 0.000
Y46.4 Iminostilbenes
0.008 0.992 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.008 0.992 0.000
I44.3 Other and unspecified atrioventricular block
0.000 0.992 0.008
Y44 Agents primarily affecting blood constituents
0.008 0.992 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.008 0.992 0.000
N20.2 Calculus of kidney with calculus of ureter
0.000 0.992 0.008
Y43.1 Antineoplastic antimetabolites
0.007 0.992 0.000
H53.9 Visual disturbance, unspecified
0.008 0.992 0.000
L29.0 Pruritus ani
0.008 0.992 0.000
H53.6 Night blindness
0.007 0.992 0.000
H53.5 Colour vision deficiencies
0.007 0.992 0.000
H53.3 Other disorders of binocular vision
0.007 0.992 0.000
N20.0 Calculus of kidney
0.000 0.992 0.008
Q23.1 Congenital insufficiency of aortic valve
0.007 0.992 0.000
N20.9 Urinary calculus, unspecified
0.000 0.993 0.007
Q20-Q28 Congenital malformations of the circulatory system
0.007 0.993 0.000
Q23 Congenital malformations of aortic and mitral valves
0.007 0.993 0.000
Y46.8 Antispasticity drugs
0.007 0.993 0.000
Y46.7 Anti-Parkinsonism drugs
0.007 0.993 0.000
Y46.5 Valproic acid
0.007 0.993 0.000
Y46.3 Deoxybarbiturates
0.007 0.993 0.000
Y46.2 Hydantoin derivatives
0.007 0.993 0.000
Y46.1 Oxazolidinediones
0.007 0.993 0.000
Y46.0 Succinimides
0.007 0.993 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.007 0.993 0.000
Q50-Q56 Congenital malformations of genital organs
0.007 0.993 0.000
Q61.2 Polycystic kidney, adult type
0.007 0.993 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.007 0.993 0.000
D60.9 Acquired pure red cell aplasia, unspecified
0.007 0.993 0.000
D60.8 Other acquired pure red cell aplasias
0.007 0.993 0.000
D60.1 Transient acquired pure red cell aplasia
0.007 0.993 0.000
D60.0 Chronic acquired pure red cell aplasia
0.007 0.993 0.000
Y57.5 X-ray contrast media
0.007 0.993 0.000
Y53.4 Other laxatives
0.007 0.993 0.000
K80.1 Calculus of gallbladder with other cholecystitis
0.000 0.993 0.007
L29 Pruritus
0.007 0.993 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
I44.0 Atrioventricular block, first degree
0.000 0.993 0.007
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.007 0.993 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.007 0.993 0.000
Y52.7 Peripheral vasodilators
0.007 0.993 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.007 0.993 0.000
Y52.1 Calcium-channel blockers
0.007 0.993 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.007 0.993 0.000
N21 Calculus of lower urinary tract
0.000 0.993 0.007
Q64 Other congenital malformations of urinary system
0.007 0.993 0.000
I44.1 Atrioventricular block, second degree
0.000 0.993 0.007
I44.5 Left posterior fascicular block
0.000 0.993 0.007
I44.4 Left anterior fascicular block
0.000 0.993 0.007
Q61.3 Polycystic kidney, unspecified
0.007 0.993 0.000
I51.8 Other ill-defined heart diseases
0.007 0.993 0.000
I51 Complications and ill-defined descriptions of heart disease
0.007 0.993 0.000
Q63 Other congenital malformations of kidney
0.007 0.993 0.000
D63.1 Anaemia in other chronic diseases classified elsewhere
0.007 0.993 0.000
Q80-Q89 Other congenital malformations
0.007 0.993 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.007 0.993 0.000
D63.0 Anaemia in neoplastic disease
0.007 0.993 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.993 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.006 0.993 0.000
Y53.7 Emetics
0.006 0.993 0.000
Y53.6 Antidiarrhoeal drugs
0.006 0.993 0.000
Y53.5 Digestants
0.006 0.993 0.000
Y53.3 Saline and osmotic laxatives
0.006 0.993 0.000
Y53.2 Stimulant laxatives
0.006 0.993 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.006 0.993 0.000
Y53.0 Histamine H2-receptor antagonists
0.006 0.993 0.000
I51.0 Cardiac septal defect, acquired
0.007 0.993 0.000
L29.9 Pruritus, unspecified
0.006 0.993 0.000
Q60 Renal agenesis and other reduction defects of kidney
0.006 0.993 0.000
Q53 Undescended testicle
0.006 0.994 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.006 0.994 0.000
Y49.5 Other antipsychotics and neuroleptics
0.006 0.994 0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver
0.006 0.994 0.000
Q00-Q07 Congenital malformations of the nervous system
0.006 0.994 0.000
Y49.9 Psychotropic drug, unspecified
0.006 0.994 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
Y49.7 Psychostimulants with abuse potential
0.006 0.994 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.006 0.994 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.006 0.994 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.006 0.994 0.000
Y49.2 Other and unspecified antidepressants
0.006 0.994 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.006 0.994 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.006 0.994 0.000
N22 Calculus of urinary tract in diseases classified elsewhere
0.000 0.994 0.006
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.006 0.994 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.006 0.994 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.006 0.994 0.000
Y47.4 Bromine compounds
0.006 0.994 0.000
Y47.3 Paraldehyde
0.006 0.994 0.000
Y47.2 Chloral derivatives
0.006 0.994 0.000
Y47.1 Benzodiazepines
0.006 0.994 0.000
Y47.0 Barbiturates, not elsewhere classified
0.006 0.994 0.000
Y48.5 Therapeutic gases
0.006 0.994 0.000
Y48.4 Anaesthetic, unspecified
0.006 0.994 0.000
Y48.3 Local anaesthetics
0.006 0.994 0.000
Y48.2 Other and unspecified general anaesthetics
0.006 0.994 0.000
Y48.1 Parenteral anaesthetics
0.006 0.994 0.000
Y48.0 Inhaled anaesthetics
0.006 0.994 0.000
Y50.9 Central nervous system stimulant, unspecified
0.006 0.994 0.000
Y50.8 Other central nervous system stimulants
0.006 0.994 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.006 0.994 0.000
Y50.1 Opioid receptor antagonists
0.006 0.994 0.000
Y50.0 Analeptics
0.006 0.994 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.006 0.994 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.006 0.994 0.000
Y55.5 Anticommon cold drugs
0.006 0.994 0.000
Y55.4 Expectorants
0.006 0.994 0.000
Y55.3 Antitussives
0.006 0.994 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.006 0.994 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.006 0.994 0.000
Y55.0 Oxytocic drugs
0.006 0.994 0.000
Y56.9 Topical agent, unspecified
0.006 0.994 0.000
Y56.8 Other topical agents
0.006 0.994 0.000
Y56.7 Dental drugs, topically applied
0.006 0.994 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.006 0.994 0.000
Y56.5 Ophthalmological drugs and preparations
0.006 0.994 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.006 0.994 0.000
Y56.3 Emollients, demulcents and protectants
0.006 0.994 0.000
Y56.2 Local astringents and local detergents
0.006 0.994 0.000
Y56.1 Antipruritics
0.006 0.994 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.006 0.994 0.000
Y58.9 Other and unspecified bacterial vaccines
0.006 0.994 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.006 0.994 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.006 0.994 0.000
Y58.5 Diphtheria vaccine
0.006 0.994 0.000
Y58.4 Tetanus vaccine
0.006 0.994 0.000
Y58.3 Plague vaccine
0.006 0.994 0.000
Y58.2 Cholera vaccine
0.006 0.994 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.006 0.994 0.000
Y58.0 BCG vaccine
0.006 0.994 0.000
Y59.9 Vaccine or biological substance, unspecified
0.006 0.994 0.000
Y59.8 Other specified vaccines and biological substances
0.006 0.994 0.000
Y59.3 Immunoglobulin
0.006 0.994 0.000
Y59.2 Protozoal vaccines
0.006 0.994 0.000
Y59.1 Rickettsial vaccines
0.006 0.994 0.000
Y59.0 Viral vaccines
0.006 0.994 0.000
D63.8 Anaemia in other chronic diseases classified elsewhere
0.006 0.994 0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.006 0.994 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.006 0.994 0.000
Y57.8 Other drugs and medicaments
0.006 0.994 0.000
Y57.7 Vitamins, not elsewhere classified
0.006 0.994 0.000
Y57.6 Other diagnostic agents
0.006 0.994 0.000
Y57.4 Pharmaceutical excipients
0.006 0.994 0.000
Y57.3 Alcohol deterrents
0.006 0.994 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.006 0.994 0.000
Y57.1 Lipotropic drugs
0.006 0.994 0.000
Y57.0 Appetite depressants [anorectics]
0.006 0.994 0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck
0.006 0.994 0.000
H53.8 Other visual disturbances
0.006 0.994 0.000
L29.8 Other pruritus
0.006 0.994 0.000
I44.6 Other and unspecified fascicular block
0.000 0.994 0.006
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.006 0.994 0.000
Q39 Congenital malformations of oesophagus
0.006 0.994 0.000
N21.0 Calculus in bladder
0.000 0.994 0.006
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.006 0.994 0.000
Q35-Q37 Cleft lip and cleft palate
0.006 0.994 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.006 0.994 0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.000 0.994 0.006
Q61.9 Cystic kidney disease, unspecified
0.006 0.994 0.000
Q61.8 Other cystic kidney diseases
0.006 0.994 0.000
Q61.5 Medullary cystic kidney
0.006 0.994 0.000
Q61.4 Renal dysplasia
0.006 0.994 0.000
Q61.1 Polycystic kidney, infantile type
0.006 0.994 0.000
Q54 Hypospadias
0.006 0.994 0.000
Q24 Other congenital malformations of heart
0.006 0.994 0.000
Q89 Other congenital malformations, not elsewhere classified
0.006 0.994 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.006 0.994 0.000
Y44.7 Plasma substitutes
0.006 0.994 0.000
Y44.6 Natural blood and blood products
0.006 0.994 0.000
Y44.5 Thrombolytic drugs
0.006 0.994 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.006 0.994 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.006 0.994 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.006 0.994 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.006 0.994 0.000
Q53.1 Undescended testicle, unilateral
0.006 0.994 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.006 0.994 0.000
Q43 Other congenital malformations of intestine
0.006 0.994 0.000
Q44.6 Cystic disease of liver
0.006 0.994 0.000
Y54.9 Mineral salts, not elsewhere classified
0.006 0.994 0.000
Y54.8 Agents affecting uric acid metabolism
0.006 0.994 0.000
Y54.7 Agents affecting calcification
0.006 0.994 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.006 0.994 0.000
Y54.5 Other diuretics
0.006 0.994 0.000
Y54.4 Loop [high-ceiling] diuretics
0.006 0.994 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.006 0.994 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.006 0.994 0.000
Y54.0 Mineralocorticoids
0.006 0.994 0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities
0.006 0.994 0.000
Q63.1 Lobulated, fused and horseshoe kidney
0.006 0.994 0.000
Q51 Congenital malformations of uterus and cervix
0.006 0.994 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.006 0.994 0.000
K82 Other diseases of gallbladder
0.000 0.994 0.006
Q61.0 Congenital single renal cyst
0.005 0.994 0.000
S02.20 Fracture of nasal bones (closed)
0.006 0.994 0.000
Q26 Congenital malformations of great veins
0.005 0.994 0.000
Q25 Congenital malformations of great arteries
0.005 0.994 0.000
Q22 Congenital malformations of pulmonary and tricuspid valves
0.005 0.994 0.000
Q20 Congenital malformations of cardiac chambers and connexions
0.005 0.994 0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified
0.005 0.994 0.000
Q23.8 Other congenital malformations of aortic and mitral valves
0.005 0.994 0.000
Q23.4 Hypoplastic left heart syndrome
0.005 0.994 0.000
Q23.3 Congenital mitral insufficiency
0.005 0.994 0.000
Q23.2 Congenital mitral stenosis
0.005 0.994 0.000
Q23.0 Congenital stenosis of aortic valve
0.005 0.994 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.994 0.000
Y41.5 Antiviral drugs
0.005 0.994 0.000
Y41.4 Anthelminthics
0.005 0.994 0.000
Y41.3 Other antiprotozoal drugs
0.005 0.994 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.994 0.000
Y41.1 Antimycobacterial drugs
0.005 0.994 0.000
Y41.0 Sulphonamides
0.005 0.994 0.000
Q56 Indeterminate sex and pseudohermaphroditism
0.005 0.995 0.000
Q55 Other congenital malformations of male genital organs
0.005 0.995 0.000
Q52 Other congenital malformations of female genitalia
0.005 0.995 0.000
Q45 Other congenital malformations of digestive system
0.005 0.995 0.000
Q42 Congenital absence, atresia and stenosis of large intestine
0.005 0.995 0.000
Q41 Congenital absence, atresia and stenosis of small intestine
0.005 0.995 0.000
Q40 Other congenital malformations of upper alimentary tract
0.005 0.995 0.000
Q85 Phakomatoses, not elsewhere classified
0.005 0.995 0.000
L20-L30 Dermatitis and eczema
0.005 0.995 0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments
0.005 0.995 0.000
L29.3 Anogenital pruritus, unspecified
0.005 0.995 0.000
L29.1 Pruritus scroti
0.005 0.995 0.000
Q12 Congenital lens malformations
0.005 0.995 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
Y51.0 Anticholinesterase agents
0.005 0.995 0.000
Q89.2 Congenital malformations of other endocrine glands
0.005 0.995 0.000
N21.9 Calculus of lower urinary tract, unspecified
0.000 0.995 0.005
N21.8 Other lower urinary tract calculus
0.000 0.995 0.005
N21.1 Calculus in urethra
0.000 0.995 0.005
Q64.9 Congenital malformation of urinary system, unspecified
0.005 0.995 0.000
Q64.8 Other specified congenital malformations of urinary system
0.005 0.995 0.000
Q64.7 Other congenital malformations of bladder and urethra
0.005 0.995 0.000
Q64.6 Congenital diverticulum of bladder
0.005 0.995 0.000
Q64.5 Congenital absence of bladder and urethra
0.005 0.995 0.000
Q64.4 Malformation of urachus
0.005 0.995 0.000
Q64.2 Congenital posterior urethral valves
0.005 0.995 0.000
Q64.1 Exstrophy of urinary bladder
0.005 0.995 0.000
Q64.0 Epispadias
0.005 0.995 0.000
Q27 Other congenital malformations of peripheral vascular system
0.005 0.995 0.000
I51.6 Cardiovascular disease, unspecified
0.005 0.995 0.000
I51.5 Myocardial degeneration
0.005 0.995 0.000
I51.4 Myocarditis, unspecified
0.005 0.995 0.000
I51.3 Intracardiac thrombosis, not elsewhere classified
0.005 0.995 0.000
I51.2 Rupture of papillary muscle, not elsewhere classified
0.005 0.995 0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified
0.005 0.995 0.000
Y44.2 Anticoagulants
0.005 0.995 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.005 0.995 0.000
Q39.4 Oesophageal web
0.005 0.995 0.000
Q63.0 Accessory kidney
0.005 0.995 0.000
Q60.0 Renal agenesis, unilateral
0.005 0.995 0.000
L27 Dermatitis due to substances taken internally
0.005 0.995 0.000
Q63.9 Congenital malformation of kidney, unspecified
0.005 0.995 0.000
Q63.8 Other specified congenital malformations of kidney
0.005 0.995 0.000
Q63.3 Hyperplastic and giant kidney
0.005 0.995 0.000
Q63.2 Ectopic kidney
0.005 0.995 0.000
Q05 Spina bifida
0.005 0.995 0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
0.005 0.995 0.000
Q84 Other congenital malformations of integument
0.005 0.995 0.000
Q83 Congenital malformations of breast
0.005 0.995 0.000
Q81 Epidermolysis bullosa
0.005 0.995 0.000
Q80 Congenital ichthyosis
0.005 0.995 0.000
L27.0 Generalised skin eruption due to drugs and medicaments
0.005 0.995 0.000
Y42.9 Other and unspecified hormone antagonists
0.005 0.995 0.000
Y42.7 Androgens and anabolic congeners
0.005 0.995 0.000
Y42.4 Oral contraceptives
0.005 0.995 0.000
Y42.2 Antithyroid drugs
0.005 0.995 0.000
Y42.1 Thyroid hormones and substitutes
0.005 0.995 0.000
Q28 Other congenital malformations of circulatory system
0.005 0.995 0.000
Q54.1 Hypospadias, penile
0.005 0.995 0.000
I44.7 Left bundle-branch block, unspecified
0.000 0.995 0.005
N41.1 Chronic prostatitis
0.000 0.995 0.005
Y54.3 Benzothiadiazine derivatives
0.005 0.995 0.000
Q82 Other congenital malformations of skin
0.005 0.995 0.000
Q21 Congenital malformations of cardiac septa
0.005 0.995 0.000
Q38 Other congenital malformations of tongue, mouth and pharynx
0.005 0.995 0.000
Q60.6 Potter's syndrome
0.005 0.995 0.000
Q60.5 Renal hypoplasia, unspecified
0.005 0.995 0.000
Q60.4 Renal hypoplasia, bilateral
0.005 0.995 0.000
Q60.3 Renal hypoplasia, unilateral
0.005 0.995 0.000
Q60.2 Renal agenesis, unspecified
0.005 0.995 0.000
Q60.1 Renal agenesis, bilateral
0.005 0.995 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.005 0.995 0.000
L29.2 Pruritus vulvae
0.005 0.995 0.000
Q53.9 Undescended testicle, unspecified
0.005 0.995 0.000
Q53.2 Undescended testicle, bilateral
0.005 0.995 0.000
Q53.0 Ectopic testis
0.005 0.995 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.005 0.995 0.000
Q24.8 Other specified congenital malformations of heart
0.005 0.995 0.000
Y45.5 4-Aminophenol derivatives
0.005 0.995 0.000
Q17 Other congenital malformations of ear
0.005 0.995 0.000
Q16 Congenital malformations of ear causing impairment of hearing
0.005 0.995 0.000
Q15 Other congenital malformations of eye
0.005 0.995 0.000
Q14 Congenital malformations of posterior segment of eye
0.005 0.995 0.000
Q13 Congenital malformations of anterior segment of eye
0.005 0.995 0.000
Q11 Anophthalmos, microphthalmos and macrophthalmos
0.005 0.995 0.000
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit
0.005 0.995 0.000
Q44.7 Other congenital malformations of liver
0.005 0.995 0.000
Q44.5 Other congenital malformations of bile ducts
0.005 0.995 0.000
Q44.4 Choledochal cyst
0.005 0.995 0.000
Q44.3 Congenital stenosis and stricture of bile ducts
0.005 0.995 0.000
Q44.2 Atresia of bile ducts
0.005 0.995 0.000
Q44.1 Other congenital malformations of gallbladder
0.005 0.995 0.000
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder
0.005 0.995 0.000
Q07 Other congenital malformations of nervous system
0.005 0.995 0.000
Q06 Other congenital malformations of spinal cord
0.005 0.995 0.000
Q04 Other congenital malformations of brain
0.005 0.995 0.000
Q03 Congenital hydrocephalus
0.005 0.995 0.000
Q01 Encephalocele
0.005 0.995 0.000
Q00 Anencephaly and similar malformations
0.005 0.995 0.000
Q02 Microcephaly
0.005 0.995 0.000
N22.8 Calculus of urinary tract in other diseases classified elsewhere
0.000 0.995 0.005
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]
0.000 0.995 0.005
Q43.0 Meckel's diverticulum
0.005 0.995 0.000
Q62.8 Other congenital malformations of ureter
0.005 0.995 0.000
Q62.7 Congenital vesico-uretero-renal reflux
0.005 0.995 0.000
Q62.6 Malposition of ureter
0.005 0.995 0.000
Q62.5 Duplication of ureter
0.005 0.995 0.000
Q62.4 Agenesis of ureter
0.005 0.995 0.000
Q62.3 Other obstructive defects of renal pelvis and ureter
0.005 0.995 0.000
Q62.2 Congenital megaloureter
0.005 0.995 0.000
Q62.1 Atresia and stenosis of ureter
0.005 0.995 0.000
Q62.0 Congenital hydronephrosis
0.005 0.995 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.995 0.000
R50.9 Fever, unspecified
0.005 0.995 0.000
Q12.0 Congenital cataract
0.005 0.995 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.004 0.995 0.000
Q18 Other congenital malformations of face and neck
0.004 0.995 0.000
Q39.9 Congenital malformation of oesophagus, unspecified
0.004 0.995 0.000
Q39.8 Other congenital malformations of oesophagus
0.004 0.995 0.000
Q39.6 Diverticulum of oesophagus
0.004 0.995 0.000
Q39.5 Congenital dilatation of oesophagus
0.004 0.995 0.000
Q39.3 Congenital stenosis and stricture of oesophagus
0.004 0.995 0.000
Q39.2 Congenital tracheooesophageal fistula without atresia
0.004 0.995 0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula
0.004 0.995 0.000
Q39.0 Atresia of oesophagus without fistula
0.004 0.995 0.000
L30 Other dermatitis
0.005 0.995 0.000
Q24.9 Congenital malformation of the heart, unspecified
0.004 0.995 0.000
Q34 Other congenital malformations of respiratory system
0.004 0.995 0.000
Q33 Congenital malformations of lung
0.004 0.995 0.000
Q32 Congenital malformations of trachea and bronchus
0.004 0.995 0.000
Q31 Congenital malformations of larynx
0.004 0.995 0.000
Q30 Congenital malformations of nose
0.004 0.995 0.000
Q37 Cleft palate with cleft lip
0.004 0.995 0.000
Q36 Cleft lip
0.004 0.995 0.000
Q35 Cleft palate
0.004 0.995 0.000
Q99 Other chromosome abnormalities, not elsewhere classified
0.004 0.995 0.000
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified
0.004 0.995 0.000
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified
0.004 0.995 0.000
Q96 Turner's syndrome
0.004 0.995 0.000
Q95 Balanced rearrangements and structural markers, not elsewhere classified
0.004 0.995 0.000
Q93 Monosomies and deletions from the autosomes, not elsewhere classified
0.004 0.995 0.000
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified
0.004 0.995 0.000
Q91 Edwards' syndrome and Patau's syndrome
0.004 0.995 0.000
Q90 Down's syndrome
0.004 0.995 0.000
Q51.2 Other doubling of uterus
0.004 0.995 0.000
Q54.8 Other hypospadias
0.004 0.995 0.000
Q54.4 Congenital chordee
0.004 0.995 0.000
Q54.3 Hypospadias, perineal
0.004 0.995 0.000
Q54.2 Hypospadias, penoscrotal
0.004 0.995 0.000
Q54.0 Hypospadias, balanic
0.004 0.995 0.000
Y45.2 Propionic acid derivatives
0.004 0.995 0.000
Q24.6 Congenital heart block
0.004 0.995 0.000
Q24.5 Malformation of coronary vessels
0.004 0.995 0.000
Q24.4 Congenital subaortic stenosis
0.004 0.995 0.000
Q24.3 Pulmonary infundibular stenosis
0.004 0.995 0.000
Q24.2 Cor triatriatum
0.004 0.995 0.000
Q24.1 Levocardia
0.004 0.995 0.000
Q24.0 Dextrocardia
0.004 0.995 0.000
Q89.9 Congenital malformation, unspecified
0.004 0.995 0.000
Q89.8 Other specified congenital malformations
0.004 0.995 0.000
Q89.7 Multiple congenital malformations, not elsewhere classified
0.004 0.995 0.000
Q89.4 Conjoined twins
0.004 0.995 0.000
Q89.3 Situs inversus
0.004 0.995 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.